BaseLaunch, a new 15-month accelerator program specifically tailored to the needs of healthcare startups has been launched. It provides handpicked ventures with access to founder-friendly venture grants, insights, industry access and state-of-the-art infrastructure, and connects them to one of the most dynamic biotech and pharma ecosystems in Europe.
The program is supported by three global biopharmaceutical companies and innovation champions Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer. Entrepreneurs with breakthrough healthcare innovations with a major focus on therapeutics or game-changing ideas and projects in diagnostics, medtech as well as related fields can apply until June 30, 2017. Ventures accepted for the final phase will receive a grant of up to 250,000 CHF, office and laboratory space at the Switzerland Innovation Park Basel Area and expertise from our Entrepreneurs-in-Residence, Advisors and Consultants. To apply or learn more about the program, please visit: www.baselaunch.ch